Mesenchymal Stem Cell-Derived Extracellular Vesicles for the Treatment of Bronchopulmonary Dysplasia
Bronchopulmonary dysplasia (BPD) is the most common chronic respiratory disease in premature infants. However, there is a lack of effective treatment. Mesenchymal stromal cells derived extracellular vesicles (MSC-EVs), as nano- and micron-sized heterogeneous vesicles secreted by MSCs, are the main m...
Main Authors: | Yufeng Xi, Rong Ju, Yujia Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-04-01
|
Series: | Frontiers in Pediatrics |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fped.2022.852034/full |
Similar Items
-
Mesenchymal stromal/stem cells and bronchopulmonary dysplasia
by: Shuqing Zhang, et al.
Published: (2023-10-01) -
Efficacy of Sildenafil in Infants with Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension
by: Kacie Dillon, et al.
Published: (2023-08-01) -
Predicting Long-Term Respiratory Outcomes in Premature Infants: Is It Time to Move beyond Bronchopulmonary Dysplasia?
by: Deepak Jain, et al.
Published: (2020-12-01) -
Present and Future of Bronchopulmonary Dysplasia
by: Luca Bonadies, et al.
Published: (2020-05-01) -
Optimizing ventilator support in severe bronchopulmonary dysplasia in the absence of conclusive evidence
by: Audrey N. Miller, et al.
Published: (2022-11-01)